19,999 Shares in Clarivate Plc (NYSE:CLVT) Purchased by Creative Planning

Creative Planning bought a new stake in Clarivate Plc (NYSE:CLVT) during the third quarter, according to the company in its most recent Form 13F filing with the SEC. The firm bought 19,999 shares of the company’s stock, valued at approximately $142,000.

Several other institutional investors have also recently bought and sold shares of the company. Baupost Group LLC MA boosted its position in Clarivate by 27.2% during the second quarter. Baupost Group LLC MA now owns 38,929,635 shares of the company’s stock valued at $221,510,000 after purchasing an additional 8,331,233 shares during the last quarter. Capital World Investors acquired a new stake in shares of Clarivate in the 1st quarter valued at approximately $30,104,000. Dimensional Fund Advisors LP increased its holdings in Clarivate by 19.5% during the second quarter. Dimensional Fund Advisors LP now owns 14,752,994 shares of the company’s stock worth $83,945,000 after buying an additional 2,409,470 shares during the last quarter. Thompson Siegel & Walmsley LLC raised its position in Clarivate by 31.5% during the second quarter. Thompson Siegel & Walmsley LLC now owns 9,726,504 shares of the company’s stock worth $55,344,000 after acquiring an additional 2,332,388 shares in the last quarter. Finally, Brown Brothers Harriman & Co. lifted its stake in Clarivate by 37.5% in the second quarter. Brown Brothers Harriman & Co. now owns 6,249,260 shares of the company’s stock valued at $35,558,000 after acquiring an additional 1,704,761 shares during the last quarter. Institutional investors own 85.72% of the company’s stock.

Insiders Place Their Bets

In related news, Director Saurabh Saha sold 17,646 shares of the business’s stock in a transaction that occurred on Friday, August 30th. The stock was sold at an average price of $6.75, for a total value of $119,110.50. Following the completion of the sale, the director now directly owns 23,741 shares in the company, valued at approximately $160,251.75. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through this link. In other news, Director Saurabh Saha sold 17,646 shares of the company’s stock in a transaction on Friday, August 30th. The stock was sold at an average price of $6.75, for a total transaction of $119,110.50. Following the completion of the sale, the director now directly owns 23,741 shares in the company, valued at approximately $160,251.75. This represents a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, insider Bar Veinstein sold 60,000 shares of the stock in a transaction on Tuesday, October 15th. The stock was sold at an average price of $7.00, for a total value of $420,000.00. Following the sale, the insider now directly owns 916,583 shares in the company, valued at approximately $6,416,081. This trade represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 197,646 shares of company stock worth $1,379,111 in the last quarter. Corporate insiders own 22.77% of the company’s stock.

Analysts Set New Price Targets

Several research analysts have recently weighed in on the stock. William Blair lowered shares of Clarivate from an “outperform” rating to a “market perform” rating in a research note on Wednesday, November 6th. Royal Bank of Canada lowered their price target on Clarivate from $7.00 to $6.00 and set a “sector perform” rating on the stock in a research report on Thursday, November 7th. Finally, Barclays cut their price objective on Clarivate from $5.00 to $4.00 and set an “underweight” rating for the company in a research report on Thursday, November 7th. Two equities research analysts have rated the stock with a sell rating, three have given a hold rating and two have assigned a buy rating to the company. According to MarketBeat.com, the stock has an average rating of “Hold” and an average target price of $7.25.

Clarivate Price Performance

Clarivate stock opened at $4.59 on Wednesday. The company has a market capitalization of $3.26 billion, a price-to-earnings ratio of -2.32 and a beta of 1.18. The stock’s 50 day moving average is $6.51 and its 200-day moving average is $6.25. The company has a current ratio of 0.88, a quick ratio of 0.90 and a debt-to-equity ratio of 0.84. Clarivate Plc has a 12 month low of $4.43 and a 12 month high of $9.60.

Clarivate (NYSE:CLVT) last posted its earnings results on Wednesday, November 6th. The company reported $0.19 earnings per share for the quarter, hitting analysts’ consensus estimates of $0.19. Clarivate had a positive return on equity of 9.69% and a negative net margin of 50.00%. The company had revenue of $622.20 million during the quarter, compared to the consensus estimate of $640.81 million. During the same quarter last year, the firm earned $0.18 earnings per share. The company’s revenue was down 3.9% on a year-over-year basis. Equities research analysts expect that Clarivate Plc will post 0.64 EPS for the current year.

Clarivate Company Profile

Clarivate Plc operates as an information services provider in the Americas, the Middle East, Africa, Europe, and the Asia Pacific. It operates through three segments: Academia & Government, Life Sciences & Healthcare, and Intellectual Property. The company offers Web of Science and InCites, that analyzes and explores the academic research landscape and manages research information; ProQuest One and Ebook Central that provides comprehensive content collections to institutions in a cost-effective manner; and Alma and Polaris, that manages academic resources and services, connect users, and support research publications.